Hoi-Wing Leung

1.1k total citations
22 papers, 782 citations indexed

About

Hoi-Wing Leung is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hoi-Wing Leung has authored 22 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Hoi-Wing Leung's work include Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Hoi-Wing Leung is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers) and MicroRNA in disease regulation (3 papers). Hoi-Wing Leung collaborates with scholars based in Hong Kong, China and United States. Hoi-Wing Leung's co-authors include Eunice Y. Lau, Terence K. Lee, Stephanie Ma, Irene Oi‐Lin Ng, Chi Ho Lin, Nicole P. Ho, Clara Bik‐San Lau, Grace Gar‐Lee Yue, Regina Cheuk‐Lam Lo and Lily K. Cheng and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Hepatology.

In The Last Decade

Hoi-Wing Leung

21 papers receiving 768 citations

Peers

Countries citing papers authored by Hoi-Wing Leung

Since Specialization

Citations

This map shows the geographic impact of Hoi-Wing Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hoi-Wing Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hoi-Wing Leung more than expected).

Fields of papers citing papers by Hoi-Wing Leung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hoi-Wing Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hoi-Wing Leung. The network helps show where Hoi-Wing Leung may publish in the future.

Co-authorship network of co-authors of Hoi-Wing Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Hoi-Wing Leung. A scholar is included among the top collaborators of Hoi-Wing Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hoi-Wing Leung. Hoi-Wing Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Update in the treatment of cirrhotic patients with portal vein thrombosis 2025 ·Clinical and Molecular Hepatology ·(unknown), Xinyi Deng, Junyang Luo, Zaibo Jiang, Fuda Xie, Bonan Chen, Hoi-Wing Leung, Ge Zhang, Ka‐Fai To, Wei Kang	0
2	A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging 2023 ·Aging Cell ·Frank W. Pun, (unknown), Hoi-Wing Leung, (unknown), Tomas Schmauck‐Medina, Sofie Lautrup, Xi Long, Bonnie Hei Man Liu, (unknown), Ivan V. Ozerov, Alex Aliper, Feng Ren, Ari J. Rosenberg, Nishant Agrawal, Evgeny Izumchenko, Evandro Fei Fang, Alex Zhavoronkov	19
3	Identification of dual-purpose therapeutic targets implicated in aging and glioblastoma multiforme using PandaOmics - an AI-enabled biological target discovery platform 2023 ·Aging ·(unknown), (unknown), Christopher X. Ren, Anastasia Shneyderman, (unknown), (unknown), (unknown), (unknown), Frank W. Pun, (unknown), Hoi-Wing Leung, Ivan V. Ozerov, Alex Aliper, Mikhail Korzinkin, Alex Zhavoronkov	11
4	Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related disease target discovery 2023 ·Aging ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vladimir Naumov, (unknown), (unknown), Hoi-Wing Leung, Frank W. Pun, Ivan V. Ozerov, Alex Aliper, Feng Ren, Alex Zhavoronkov	19
5	Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma 2022 ·Cancer Research ·(unknown), (unknown), Lei Zhou, Martina Mang Leng Lei, Hoi-Wing Leung, Man Tong, Tin Lok Wong, Eunice Y. Lau, Irene Oi‐Lin Ng, Jin Ding, Jing‐Ping Yun, Jun Yu, (unknown), Chi Ho Lin, Dan Lindholm, (unknown), Jonathan D. Cybulski, D. M. H. Baker, Stephanie Ma, Terence K. Lee	71
6	Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform 2022 ·Frontiers in Aging Neuroscience ·Frank W. Pun, Bonnie Hei Man Liu, Xi Long, Hoi-Wing Leung, (unknown), (unknown), Junli Gao, Anastasia Shneyderman, Ivan V. Ozerov, Ju Wang, Feng Ren, Alexander Aliper, Evelyne Bischof, Evgeny Izumchenko, (unknown), Ke Zhang, (unknown), Jeffrey D. Rothstein, Merit Cudkowicz, Alex Zhavoronkov	59
7	Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine 2022 ·Aging ·Frank W. Pun, (unknown), Hoi-Wing Leung, Bonnie Hei Man Liu, Xi Long, Ivan V. Ozerov, Ju Wang, Feng Ren, Alexander Aliper, Evgeny Izumchenko, Alexey Moskalev, João Pedro de Magalhães, Alex Zhavoronkov	40
8	EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma 2021 ·Cancer Research ·Hoi-Wing Leung, Carmen Oi Ning Leung, Eunice Y. Lau, (unknown), (unknown), Martina Mang Leng Lei, (unknown), Man Tong, Vincent W. Keng, Cong Ma, Qian Zhao, Irene Oi‐Lin Ng, Stephanie Ma, Terence K. Lee	102
9	The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression 2021 ·Cell Death and Disease ·Nicole P. Ho, Carmen Oi Ning Leung, Tin Lok Wong, Eunice Y. Lau, Martina Mang Leng Lei, (unknown), Hoi-Wing Leung, Man Tong, Irene Oi‐Lin Ng, Jing‐Ping Yun, Stephanie Ma, Terence K. Lee	27
10	NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma 2020 ·Cancer Letters ·Hoi-Wing Leung, Eunice Y. Lau, Carmen Oi Ning Leung, Martina Mang Leng Lei, (unknown), Victor Ma, William C. Cho, Irene Oi‐Lin Ng, Jing‐Ping Yun, Shaohang Cai, Hua Yu, Stephanie Ma, Terence K. Lee	46
11	Is Danggui Safe to be Taken by Breast Cancer Patients?—A Skepticism Finally Answered by Comprehensive Preclinical Evidence 2019 ·Frontiers in Pharmacology ·Grace Gar‐Lee Yue, (unknown), Hoi-Wing Leung, Si Gao, (unknown), Zhixiu Lin, Bonita K.B. Law, Gary M. Tse, Clara Bik‐San Lau	6
12	IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma 2018 ·Cancer Research ·Bowie Y. Cheng, Eunice Y. Lau, Hoi-Wing Leung, Carmen Oi‐Ning Leung, Nicole P. Ho, (unknown), Lily K. Cheng, Chi Ho Lin, Regina Cheuk‐Lam Lo, Stephanie Ma, Irene Oi‐Lin Ng, Terence K. Lee	83
13	Evaluation of the safety profiles of estrogenic Chinese herbal medicines in breast cancer 2018 ·Phytomedicine ·Grace Gar‐Lee Yue, (unknown), Hoi-Wing Leung, Si Gao, (unknown), Zhi‐Xiu Lin, Gary M. Tse, Clara Bik‐San Lau	10
14	The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells 2018 ·Cancer Chemotherapy and Pharmacology ·Hoi-Wing Leung, Chun‐Hay Ko, Grace Gar‐Lee Yue, Ingrid Herr, Clara Bik‐San Lau	20
15	Abstract 1986: IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma 2018 ·Cancer Research ·Bowie Y. Cheng, Hoi-Wing Leung, Eunice Y. Lau, Irene Oi‐Lin Ng, (unknown)	1
16	Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation 2017 ·Journal of Hepatology ·(unknown), Eunice Y. Lau, Hoi-Wing Leung, Jessica Lo, Nicole P. Ho, Lily K. Cheng, Stephanie Ma, Chi Ho Lin, John A. Copland, Jin Ding, Regina Cheuk‐Lam Lo, Irene Oi‐Lin Ng, Terence K. Lee	139
17	Cyclopeptide RA-V inhibits cell adhesion and invasion in both estrogen receptor positive and negative breast cancer cells via PI3K/AKT and NF-κB signaling pathways 2015 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Hoi-Wing Leung, Zhe Wang, Grace Gar‐Lee Yue, Simeng Zhao, Julia Kin-Ming Lee, Kwok‐Pui Fung, Ping‐Chung Leung, Clara Bik‐San Lau, Ning‐Hua Tan	26
18	Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite 2015 ·Scientific Reports ·Grace Gar‐Lee Yue, Julia Kin-Ming Lee, Hin-Fai Kwok, Ling Cheng, Eric C. Wong, Lei Jiang, (unknown), Hoi-Wing Leung, (unknown), Ping‐Chung Leung, Kwok‐Pui Fung, Clara Bik‐San Lau	40
19	RA-XII inhibits tumour growth and metastasis in breast tumour-bearing mice via reducing cell adhesion and invasion and promoting matrix degradation 2015 ·Scientific Reports ·Hoi-Wing Leung, Simeng Zhao, Grace Gar‐Lee Yue, Julia Kin-Ming Lee, Kwok‐Pui Fung, Ping‐Chung Leung, Ning‐Hua Tan, Clara Bik‐San Lau	30
20	Anti-angiogenesis and immunomodulatory activities of an anti-tumor sesquiterpene bigelovin isolated from Inula helianthus-aquatica 2012 ·European Journal of Medicinal Chemistry ·Grace Gar‐Lee Yue, Ben Chung-Lap Chan, Hin-Fai Kwok, (unknown), Hoi-Wing Leung, Chang‐Jiu Ji, Kwok‐Pui Fung, Ping‐Chung Leung, Ning‐Hua Tan, Clara Bik‐San Lau	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact